We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Politics > F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters
F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters
Politics

F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters

Last updated: December 30, 2021 5:48 pm
Editorial Board Published December 30, 2021
Share
SHARE
merlin 187711275 c1f6feae 7f30 48df 91c0 f1188f1bfe64 facebookJumbo

WASHINGTON — The Food and Drug Administration is planning to broaden eligibility for coronavirus vaccine booster doses on Monday, allowing 12- to 15-year-olds to receive third doses of Pfizer-BioNTech’s vaccine, according to people familiar with the agency’s deliberations.

Regulators also plan to allow both adolescents and adults to seek an extra shot of Pfizer’s vaccine five months after receiving a second dose, instead of the current period of six months. A booster shot is also expected to be authorized for younger children, ages 5 to 11, with immune deficiencies.

The Centers for Disease Control and Prevention’s vaccine advisory committee is planning to meet by the middle of next week to vote on whether to recommend the changes. If the committee agrees with the F.D.A.’s authorizations, Dr. Rochelle P. Walensky, the C.D.C. director, is expected to promptly endorse the revisions.

The move to expand boosters comes as the highly contagious Omicron variant is infecting a record number of Americans with the coronavirus, putting more pressure on hospitals already deluged by Covid-19 patients from the Delta variant.

More than 70 percent of people 12 years and older in the United States are fully vaccinated, according to the C.D.C. Children can better withstand coronavirus infections, but in rare instances still become very sick and even die. At least 1.8 million adolescents between 12 and 15 years old have tested positive for the virus, according to the C.D.C.

The F.D.A. had hoped to announce its decision as early as Thursday, the people familiar with the deliberations said, but agreed to wait until Monday because Dr. Walensky said she wanted to hear recommendations from her agency’s outside advisory group before signing off on the changes. That group, which has met throughout the pandemic to consider F.D.A. decisions around vaccines, might not meet until Wednesday.

The two agencies share responsibility for setting the nation’s vaccine policy and have worked to present a unified front in their reviews of booster shots. But the F.D.A. has been more willing to act without the advice of its outside advisory committee, with some top officials arguing that the agency needs to respond as quickly as possible in the face of the ongoing public health crisis.

Updated 

Dec. 30, 2021, 6:38 p.m. ET

Federal regulators based their decision at least in part on data from Israel that showed no serious safety concerns in thousands of 12- to 15-year-olds who received a third dose of the Pfizer vaccine. There were no reports of myocarditis, a rare side effect seen mostly in younger men that has been linked to the Pfizer and Moderna vaccines. The condition involves inflammation of the heart muscle.

The F.D.A. wants to allow a booster dose as early as five months after the second Pfizer dose in part because Israeli data suggests that the shorter interval is effective, according to people familiar with the government’s deliberations.

One recent South African study showed that the effectiveness of Pfizer’s vaccine against severe illness and hospitalization was about 70 percent after two doses.

The Coronavirus Pandemic: Key Things to Know


Card 1 of 4

The U.S. surge The U.S. record for daily coronavirus cases has been broken, as two highly contagious variants — Delta and Omicron — have spread across the country. The seven-day average of U.S. cases topped 267,000 on Tuesday, according to a New York Times database.

New C.D.C. guidelines Hoping to prevent further disruptions to daily life, the C.D.C. reduced the period that certain infected Americans must sequester to five days from 10. This change applies only to those without symptoms, or those without fevers whose other symptoms are improving.

Pfizer and BioNTech, its German partner, have both said their studies show that a third dose is needed to protect against Omicron. Dr. Albert Bourla, the chief executive officer of Pfizer, said this month that while two doses may still prevent severe disease from Omicron, a third strengthens protection.

Dr. Ugur Sahin, the chief executive of BioNTech, said three doses “could still offer a sufficient level of protection from disease of any severity” caused by the variant.

Although the F.D.A. convened its outside advisory committee repeatedly earlier this year, it has not asked the committee for recommendations before its most recent decisions to expand boosters.

Dr. Walensky this month endorsed offering Pfizer-BioNTech booster shots to 16- and 17-year-olds without convening her agency’s expert committee. But she was unwilling to do that for younger adolescents, people familiar with the government’s deliberations said.

Some outside experts have argued that in bypassing the outside committees, the C.D.C. and F.D.A. were wrongly limiting public discussion about the evidence to justify expanding the use of boosters.

You Might Also Like

Trump posts weird meme of himself chasing Obama in O.J. Simpson spoof

The ‘new’ Andrew Cuomo hits the streets of NYC: Will it’s sufficient?

NYC mayoral candidate Zohran Mamdani brings in nationwide gamers in revamp of marketing campaign workers

Trump received’t rule out pardon for Ghislaine Maxwell amid Epstein scandal

Mayor Adams takes a swipe at Mamdani journey to Uganda, then says he was solely kidding round

TAGGED:The Washington Mail
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Canadian examine reveals alcohol-related deaths up 18% throughout pandemic
Health

Canadian examine reveals alcohol-related deaths up 18% throughout pandemic

Editorial Board February 3, 2025
Trump slams MAGA ‘weaklings’ for demanding Epstein recordsdata launch
Where Do Travelers Still Need to Wear Masks?
Strong Job Gains in March Keep a Flame Under the Recovery
Jack Dorsey’s Twitter Departure Hints at Big Tech’s Restlessness

You Might Also Like

South Park creators provide cheeky ‘apology’ for episode mocking Trump
Politics

South Park creators provide cheeky ‘apology’ for episode mocking Trump

July 25, 2025
Hackers take over New Jersey election assembly with porn, racist language
Politics

Hackers take over New Jersey election assembly with porn, racist language

July 24, 2025
Hochul open to redistricting New York amid Trump push for Republican seats
Politics

Hochul open to redistricting New York amid Trump push for Republican seats

July 24, 2025
US cuts brief its Gaza ceasefire talks and accuses Hamas of missing ‘good faith’
Politics

US cuts brief its Gaza ceasefire talks and accuses Hamas of missing ‘good faith’

July 24, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?